South Africa, Maverick Citizen, Maverick News Trump ends SA’s HIV and TB research grants, endangering lifesaving, world class work by: Mia Malan
Maverick Citizen ‘Fund research not Tesla trucks’: The HIV casualties of Trump’s war on science by: Mia Malan
Africa, South Africa, Maverick Citizen The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar by: Ida Jooste
South Africa, Maverick Citizen Some Pepfar projects reinstated: a lifeline for HIV prevention as legal battle unfolds by: Mia Malan
Maverick Citizen, Our Burning Planet COP29’s final day — developing nations demand climate financing as wealthy countries remain hesitant by: Linda Pretorius and Mia Malan
Maverick Citizen From heatwaves to hunger: five ways climate change is compromising global health security by: Mia Malan and Linda Pretorius
Business Maverick, South Africa, Maverick Citizen, Maverick News Medical aids in their current form are out under NHI — even if it means the end of the GNU, says Motsoaledi by: Mia Malan
Maverick Citizen Lenacapavir — what it would it take to get the six-monthly anti-HIV jab to South Africa by: Mia Malan and Linda Pretorius
South Africa, Maverick Citizen Health department mulls new anti-HIV injection that could cut infection rates by a quarter by: Mia Malan and Linda Pretorius
South Africa, Maverick Citizen, Maverick News More than a million South Africans have used the HIV prevention pill by: Laura Grant and Mia Malan
South Africa, Maverick Citizen, COVID-19, Maverick News The fine line between wrong and almost right — and how that plays out during pandemics by: Nina Acharya, Helene-Mari van der Westhuizen, Mia Malan and Dave Chokshi
South Africa, Maverick Citizen, Maverick News More bullying? J&J will be investigated for high TB drug prices and abuse of patent laws by: Mia Malan for the Bhekisisa Centre for Health Journalism